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Evidence suggests that pre-ischeamic conditioning (PIC) offers protection against a subsequent
ischeamic event. Although some brain areas such as the hippocampus have received much attention,
the receptor mechanisms of PIC in other brain regions are unknown. We have previously shown that
10 min oxygen and glucose deprivation (OGD) evokes tolerance to a second OGD event in the caudate.
Here we further examine the effect of length of conditioning event on the second OGD event. Caudate
mouse brain slices were superfused with artiﬁcial cerebro-spinal ﬂuid (aCSF) bubbled with 95%O2/
5%CO2. OGD was achieved by reducing the aCSF glucose concentration and by bubbling with 95%N2/
5%CO2. After approximately 5 min OGD a large dopamine efﬂux was observed, presumably caused by
anoxic depolarisation. On applying a second OGD event, 60 min later, dopamine efﬂux was delayed and
reduced. We ﬁrst examined the effect of varying the length of the conditioning event from 5 to 40 min
and found tolerance to PIC increased with increasing duration of conditioning. We then examined the
receptor mechanism(s) underlying PIC. We found that pre-incubation with either MK-801 or
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) reduced tolerance to the second OGD event. These data
suggest that either N-methyl-D-aspartate (NMDA) or adenosine A1 receptor activation evokes PIC in the
mouse caudate.
& 2012 Elsevier B.V. Open access under CC BY license. 1. Introduction
Around 80% of strokes are ischeamic rather than haemorrhagic
(Donnan et al., 2008) in that they involve an interruption of the
blood supply to a given region of the brain. Ischeamic stroke
causes the death of brain tissue at the site of blood ﬂow
interruption and toxicity spreads to surrounding brain tissue as
pathological mechanisms, such as glutamate excitotoxicity, pro-
gress. At present, treatments for stroke focus on inhibiting or
reducing blood vessel occlusions. There are no proven treatments
aimed at reducing neurotoxicity per se, despite its potential for
inhibiting the consequences of an ischeamic event.
The caudate contains a high level of dopaminergic and gluta-
matergic input (Graybiel, 1990) and is particularly vulnerable to
ischeamic damage. This has been shown both experimentally
following middle cerebral artery occlusions in rats (Dijkhuizen
et al., 1998; Kumral et al., 1999) and clinically in humans (Caplan
et al., 1990; Payabvash et al., 2011). Most of the pre-clinical
research on the mechanisms of ischeamic damage has focused on
hippocampal or cortical glutamatergic mechanisms, particularly).
icense. focusing on the glutamate N-methyl-D-aspartate (NMDA) recep-
tor. However, in other brain areas, other neurotransmitters,
including dopamine, contribute to ischeamic damage. Massive
release of dopamine occurs in the caudate in response to anoxia
(Kondoh et al., 1995) coinciding with anoxic depolarisation
(Toner and Stamford, 1997a) and dopamine levels during ischae-
mia reach neurotoxic levels (Lieb et al., 1995). Oxygen and
glucose deprivation (OGD) evoked dopamine release is partly a
consequence of calcium-mediated cell depolarisation via voltage-
gated calcium channels resulting from NMDA receptor activation
(Toner and Stamford, 1997b; Yoshimoto et al., 2009) as well as
reversal of dopamine transporters (Kim et al., 1995) and ATP
shortage (Toner and Stamford, 1999). This aberrant release of
dopamine from ischeamic neurons exerts neurotoxic effects through
the generation of free radicals (Lancelot et al., 1995). Thus, like
glutamate in the hippocampus, not only is caudate dopamine release
a consequence of ischaemia, it can also cause further neurotoxicity.
Pre-ischeamic conditioning (PIC) is an endogenous neuroprotec-
tive mechanism by which a sub-lethal conditioning event provides
tolerance to a subsequent ischeamic event (Dirnagl et al., 2009). We
have previously examined OGD-evoked dopamine efﬂux in mouse
(Davidson et al., 2011a) and rat (Davidson et al., 2011b) caudate
brain slices and showed tolerance to OGD in the caudate 60 min
after a 10 min OGD PIC event (Davidson et al., 2011b). This is an
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but focus mostly on the hippocampus and cortex. Although the
exact mechanisms underlying PIC in the brain are unknown,
glutamate is most likely a primary mediator. It is a key neurotoxic
transmitter in the sequence of stroke pathophysiology acting on a-
amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and
NMDA receptors to induce massive calcium inﬂux. However, sub-
lethal concentrations of NMDAmay provide neuroprotection against
a further and more severe excitotoxic event (Jiang et al., 2003), and
NMDA receptor blockade attenuates these effects in cortical cell
culture (Grabb and Choi, 1999). Both adenosine A1 receptors and
NMDA-type glutamate receptors have been shown to be involved in
PIC in vitro (Perez-Pinzon et al., 1996; Kasischke et al., 1996) and
in vivo (Saleh et al., 2009; Nakamura et al., 2002), and may act
through ATP-dependent Kþ-channels (Perez-Pinzon and Born,
1999), to bring about down-regulation of neuronal metabolic
activity, and through Ca2þ-dependent nitric oxide signalling
(Centeno et al., 1999), reducing neuronal susceptibility to death.
Understanding the neurochemical mechanisms underlying PIC’s
protective effects may suggest novel pharmacological strategies for
neuroprotection in vulnerable individuals.
The present study used fast cyclic voltammetry in mouse
caudate slices to further examine the effect of PIC on OGD-
evoked dopamine release. Dopamine efﬂux after OGD in rodent
caudate slices has been shown to be very similar to that seen
in vivo after cardiac arrest (Toner and Stamford, 1996). We aimed
to (1) ascertain the optimum PIC duration at which neuroprotec-
tion to subsequent OGD insult is conferred in the caudate;
(2) assess whether blockade of adenosine A1 or glutamate NMDA
receptor signalling affects PIC.Fig. 1. Voltammetry input voltage waveform, current at carbon electrode and
subtracted voltammogram showing dopamine oxidation and reduction peaks.
(A) Input voltage waveform to carbon electrode. The voltage scan goes from 0 to
1 to þ1.4 to 1 and back to 0 V at 480 V/s. The whole scan takes 20 ms. (B) The
current at the carbon electrode after applying the input voltage in aCSF and in the
presence of 10 mM dopamine. The two scans are superimposed except for a small
increase at around 600 mV (where dopamine oxidises giving off two electrons)
and at 200 mV where dopamine is reduced. (C) The voltammogram is derived
from B and obtained by subtracting the current at the electrode in aCSF from the
current at the electrode in the presence of dopamine, leaving only the Faradaic
current from dopamine oxidation and reduction. Note the oxidation peak at
600 mV and the reduction peak at 200 mV, indicative of dopamine in the
caudate.2. Materials and methods
2.1. Animals
Adult male mice (C57BL/6; c30 g) kept on a 12/12 h light dark
cycle with freely available food and water were killed by cervical
dislocation with no anaesthesia, an approved schedule 1 method.
Anaesthetics are neuroprotective in this model (Mathews et al.,
2001, Toner et al., 2001).
2.2. Brain slice preparation
Mouse caudate slices were prepared as previously described
(Davidson et al., 2011a). Brains were extracted while irrigated
with ice-cold aCSF. A block containing the caudate was glued to
the chuck of a vibratome. Coronal sections (400 mm) were made
through the caudate and transferred into a mesh slice saver
immersed in aCSF bubbled with 95% O2/5% CO2, at room tem-
perature (2171 1C). The slices were equilibrated in the slice saver
to allow recovery from trauma associated with slicing (Toner and
Stamford, 1996). We took multiple slices from each mouse
(typically 2), but each slice was used in a different experiment
such that in one experimental group each slice was from a
different mouse.
Following equilibration, slices were transferred to the slice
chamber (33.070.5 1C) and continuously superfused with aCSF
(250 ml/h) for 45 min. The perfusion medium was then switched
to OGD aCSF for 0–40 min depending on the experiment (see
later) after which slices were superfused for a further 60 min in
aCSF and then exposed to a second OGD event.
The composition of aCSF was Maintenance aCSF (mM): NaCl
(126.0), KCl (2.0), KH2PO4 (1.4), MgSO4 (2.0), NaHCO3 (26.0), CaCl2
(2.4), (þ)-glucose (10.0), bubbled for at least 60 min with 95% O2/
5% CO2. OGD aCSF (mM): NaCl (1 2 6), KCl (2.0), KH2PO4 (1.4),MgSO4 (2.0), NaHCO3 (26.0), CaCl2 (2.4), (þ)-glucose (2.0),
bubbled for at least 60 min with 95% N2/5% CO2.2.3. Fast cyclic voltammetry (FCV)
Extracellular dopamine concentrations in the dorso-lateral
caudate nucleus were measured by FCV at carbon ﬁbre micro-
electrodes. Carbon electrodes were made by inserting an 8 mm
diameter carbon ﬁbre into a 10 cm length borosilicate glass
capillary (o.d., 2.0 mm; i.d., 1.16 mm: Harvard Apparatus, UK),
which was pulled using an PE21 electrode puller (Narishige,
Japan), such that the carbon ﬁbre protruded from the pulled tip.
The carbon ﬁbre was then cut to a length of 75 mm.
A stainless steel auxiliary electrode and a Ag/AgCl reference
electrode were placed in the slice chamber remote from the slice.
Voltammetric scans (1.0 to þ1.4 V vs Ag/AgCl, 480 V/s) were
applied at 1 Hz using a Millar voltammeter (PD Systems, UK).
Under these conditions dopamine oxidised at þ600 mV and
reduced at 200 mV (Fig. 1). Voltammetric scans were saved
using Clampex 9.0 (Molecular Devices, USA). Following each
experiment, the electrode was calibrated in dopamine (10 mM),
and measurements made during the experiments were converted
to dopamine concentrations.
After the slice was placed in the slice chamber, the electrode
tip was positioned approximately 100 mm below the slice surface
in the dorso-lateral caudate, using a micromanipulator. Recording
started immediately as this allowed us to monitor the stability of
the slice as on some occasions (e.g. poor slice health) the slice can
spontaneously release large amounts of dopamine (Davidson
et al., 2011a). Perfusion with OGD aCSF typically evoked a large
increase in dopamine from the slice (Fig. 2) and four parameters
of dopamine release were measured (1) time to onset of dopa-
mine release from the initiation of OGD (T-on); (2) time taken to
reach maximum dopamine release after the onset of release
(T-peak); (3) maximum extracellular dopamine concentration
(peak-dopamine); and (4) mean rate of dopamine release (dDA/dt)
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et al., 2011a, b).2.4. Pre-ischeamic conditioning protocol.
2.4.1. Protocol 1: effect of length of PIC event on evoked tolerance
After 45 min equilibration a slice was exposed to 0, 5, 10, 15,
20, 30 or 40 min OGD. Thereafter the slice was exposed to 60 min
of oxygenated aCSF and then exposed to a second OGD event of atE. 20 min PIC
D. 15 min PIC
A. no PIC 
B. 5 min PIC
C. 10 min PIC
F. 30 min PIC
G. 40 min PIC
OGD
t-peak
peak-DA
dDA/dt
t-on
from start of OGD
5 µM
100 s
Fig. 2. Raw data and variables measured during conditioning experiments. Top
panel shows typical experiments for 5–40 min PIC followed 60 min later by a
second OGD event (black bar, 20 min). The vertical dotted line shows the start of
the ﬁrst OGD event (i.e. the PIC event). The caudate brain slice is superfused with
oxygenated aCSF for 45 min and then subjected to 0–40 min OGD. After about
5 min we see a massive and fast increase in dopamine of approximately 15 mM
(C–G). Panel A shows 125 min of data, with subsequent panels showing slightly
longer traces, depending on the length of PIC, up to 165 min for panel G. The lower
panel shows the dopamine efﬂux event in more detail and the parameters we
measure; T-on is the time from the start of OGD until dopamine efﬂux; T-peak is
the time from the start of dopamine efﬂux until peak dopamine efﬂux; peak-DA is
the maximum dopamine concentration measured; dDA/dt is the rate of change of
dopamine efﬂux (nM/s).least 20 min duration. Thus we could examine the effect PIC
(0–40 min) on the second OGD event 60 min later (Figs. 2 and 3).
2.4.2. Protocol 2: effect of NMDA- or adenosine-A1 receptor
antagonists on PIC
Wemeasured the effect of the adenosine-A1 receptor antagonist
8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 5 mM) and of the
NMDA receptor antagonist, MK-801 (10 mM) on the tolerance
evoked by 10 min PIC. The slice was superfused with aCSF contain-
ing either DPCPX or MK-801 for 45 min. The superfusate was then
changed to OGD aCSF containing the respective drug, for 10 min,
after which the superfusion aCSF was switched to drug-free aCSF
for 60 min, then to drug-free OGD for at least 20 min. We used a
second OGD event of 20 min or more (vs 10 min for the condition-
ing event) because in preliminary experiments the OGD-evoked
dopamine efﬂux was found to be delayed to such an extent that on
some occasions 10 min OGD is not long enough to evoke dopamine
efﬂux.
On completion of these protocols some slices were removed
from the slice chamber and prepared for TTC staining to assess
mitochondrial function, or for HPLC analysis of tissue content of
dopamine, as described below.
2.5. Triphenyltetrazolium chloride (TTC) staining
After OGD superfusion, slices were incubated in aCSF at room
temperature (2171 1C) for 30 min, then transferred into sterile
cell culture wells and stained with TTC (2%w/v in 0.9% NaCl) for
30 min in the absence of light. The slices were then ﬁxed with 4%
paraformaldehyde solution, photographed and the percentage of
the caudate area stained was assessed using Image software (Beta
4.0.2, Scion Corporation, USA).
2.6. High performance liquid chromotography (HPLC)
On termination of FCV experiments, slices for HPLC analysis were
removed from the chamber and the caudate dissected out on ice,
placed in a microcentrifuge tube and weighed. Perchloric acid (0.2 N,
500 ml) was added to the tube and the tissue was homogenised for
20 s (Tissue-tearor; Biospec Products). The homogenate was cen-
trifuged (6000 rpm, 30 min, 21 1C), and the supernatant taken for
HPLC analysis. A 15 ml aliquot of sample was injected automatically
and separation was achieved on a C18 Luna reverse phase column
(1001.0 mm; 5 mm; Phenomenex), with a mobile phase compris-
ing 75.0 mM NaH2PO4, 1.2 mM octane sulphonic acid, 1.0 mM EDTA
and 10% methanol, pH 3.7. The mobile phase was delivered at
110 ml/min, using a Jasco high pressure pump. Electrochemical
detection was at a glassy carbon working electrode, set at 700 mV
relative to Ag/AgCl, using an Antec Intro electrochemical detector
incorporating a VT-03 low volume ﬂow cell (Antec Instruments).
The concentration of dopamine was measured relative to standard
solutions (100 nM), using ChromPerfect data analysis software
(Justice Laboratory). Each sample was run in duplicate, and the
mean tissue content of dopamine was calculated and normalised to
the wet weight of tissue in nM/mg.
2.7. Drugs and chemicals
All chemicals were purchased from Sigma Aldrich. DPCPX was
initially dissolved in DSMO to make a stock solution of 10 mM,
and then diluted in aCSF to give a working concentration of 5 mM,
a concentration that has previously been shown to attenuate
anoxia-evoked PIC in hippocampal brain slice preparations
(Perez-Pinzon et al., 1996). MK-801 was initially dissolved in
deionised water to a stock solution of 10 mM and then diluted in
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control or PIC experiments with DMSO control (DPCPX vehicle
controls) were no different from these experiments without
DMSO (MK-801 vehicle control) and so all vehicle control experi-
ments were combined.2.8. Statistics
Where the effects of one condition were to be compared with
another, a two-tailed, unpaired student t-test was done. When
there were more than two conditions with one variable, a one-
way analysis of variance (ANOVA) was done with post hoc
analysis with Tukey’s post test for multiple comparisons. A two-
way ANOVA was done when two independent factors were
present. A probability of Po0.05 was considered signiﬁcant.
SigmaStat software was used for all statistical analysis. Values
are means7SEM.3. Results
Consistent OGD-evoked dopamine release occurred 350782 s
after the onset of OGD, taking 148717 s to achieve peak-
dopamine efﬂux of 20.374.0 mM. The rate of change of dopamine
efﬂux was 73719 nM/s (Fig. 3 and Table 1).Fig. 3. Time to onset of dopamine efﬂux and voltammograms from the conditioning a
from 0 to 40 min OGD there was a corresponding increase in T-on of OGD-evoked dopam
nPo0.05 vs 0 min; nnPo0.05 vs 0, 5, 10 and 15 min. N¼5–7 (given in individual column
in the top trace, while the lower traces show the peaks for the second OGD event. Note t
than the lower trace i.e. less dopamine is released on the second OGD event. The upp
corresponds to the voltage input waveform shown in Fig. 1A. Dopamine oxidation pea
show that we are measuring dopamine both at the ﬁrst and second OGD events. The init
A which is lower).
Table 1
Effect of increasing the conditioning period on dopamine efﬂux after a second ODG ev
DA efﬂux parameter Pre-ischaemic conditioning time (min)
0 (n¼7) 5 (n¼5) 10 (n¼6)
T-peak (s) 148717 345755n 194724
Peak-DA (mM) 20.374.0a 8.171.1 5.070.8
dDA/dt (nM/s) 73719b 2677 2974
In addition to the effects of various conditioning times on T-on (Fig. 3), other dopamin
a Po0.05 vs all other groups.
b Po0.05 vs all other groups except 15 min PIC. T-peak¼time from the start of d
change of dopamine efﬂux.3.1. Effect of pre-ischeamic conditioning length on the second OGD
event.
Single PIC events of 5–40 min evoked a signiﬁcant delay in
T-on of OGD-evoked dopamine release 60 min later
(F(6,41)¼46.88, Po0.05); Fig. 3). The 5 min PIC event also
lengthened T-peak from about 148 to 345 s (F(6, 41)¼3.867,
Po0.05) but the other PIC events (10–40 min) had no effect on
T-peak. All PIC events (5–40 min) signiﬁcantly reduced the OGD-
evoked peak-dopamine, from 20.374.0 mM in control slices to
3.671.1 mM 60 min after 40 min PIC, F(6, 41)¼7.58, Po0.05. All
PIC events (5–40 min) signiﬁcantly reduced dDA/dt, from 73 nM/s
in control slices to 19 nM/s 60 min after 40 min PIC (F(6, 41)¼
4.39, Po0.05; Table 1).3.2. Effect of post-PIC incubation on caudate tissue dopamine
content
It is possible that less dopamine is evoked on the second OGD
event because there is less dopamine in the dopamine terminals
either because (1) much was released on the ﬁrst OGD event or
(2) the slices’ ability to synthesise dopamine was now compro-
mised. We therefore examined caudate dopamine tissue content
immediately after the ﬁrst OGD event and, in different slices, after
60 min incubation following OGD. The data show that dopaminend ﬁnal OGD events. Left panel: As the length of the conditioning event increased
ine efﬂux on the second OGD event 60 min later (Fig. 2 upper panel for raw data).
s). Right panel A–F shows the oxidation and reduction peaks for the ﬁrst OGD event
hat in all cases, except 5 min PIC, the upper trace dopamine oxidation peak is larger
er traces are offset to aid clarity. The 20 ms of data is shown in each trace which
ks are at approximately 600 mV and reduction peaks are at 200 mV. These data
ial OGD-evoked oxidation peaks correspond to approximately 20 mM (except panel
ent 60 min later.
15 (n¼6) 20 (n¼7) 30 (n¼6) 40 (n¼5)
167720 242736 239726 258747
8.372.1 5.171.4 5.071.3 3.671.1
4678 2176 2276 1979
e efﬂux parameters are shown in this table. nPo0.05 vs 0 and 15 min PIC.
opamine efﬂux to peak efﬂux; peak-DA¼peak dopamine efﬂux; dDA/dt¼rate of
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control levels after 60 min reperfusion (Fig. 4A).
There was a main effect of PIC time (F(3, 33)¼29.95, Po0.05)
and a PIC time X incubation interaction (F(3,33)¼5.79, Po0.05).
Tukey’s test revealed that, immediately after the PIC event, all
three PIC treatments (10, 20 and 30 min) had reduced the
dopamine content vs no PIC (all, Po0.05). However, after
60 min reperfusion dopamine content partially recovered in that
now only the 20 and 30 min PIC was different from controls (both
Po0.05, Fig. 4A). Within the control group (0 min PIC) dopamine
content fell during the 60 min reperfusion (Po0.05) while in the
30 min PIC group dopamine content increased over the 60 minpre-ischaemic conditionin
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Fig. 4. Effect of different conditioning periods and reperfusion on caudate dopamine con
45 min then exposed to 0–30 min OGD. Immediately after OGD (0 min incubations in ﬁ
allowed to recover for 60 min after OGD (60 min incubation in the ﬁgure legend) afte
incubation after OGD we found that 10, 20 and 30 min of OGD caused a reduction in do
only the 20 and 30 min OGD slices were different from controls (nnnPo0.05 vs control).
further 60 min incubation (nPo0.05). When comparing the caudate immediately afte
dopamine content recovered, although not quite to control levels (nPo0.05 0 vs 60 m
examined TTC staining in caudate slices that had been exposed to 0–20 min OGD and th
(nPo0.05 vs 0 min OGD). Thus 10 and 15 min OGD do not appear to cause permanen
dysfunction for at least 60 min after the end of OGD. N¼4–6. Right panel: (C) control cau
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Fig. 5. Effect of MK-801 or DPCPX on OGD and conditioning. Caudate slices were superf
event of either 0 or 10 min OGD, during which the vehicle, MK-801 or DPCPX was still p
exposed to a second OGD. The T-on of the second OGD evoked dopamine efﬂux event ar
tolerance to a second OGD event 60 min later (nnPo0.05). MK-801 (10 mM) increased T
attenuated (nnnPo0.05). (B) As in panel A, 10 min PIC evoked tolerance to a second OG
increase in T-on evoked by PIC (nnnPo0.05). N¼6–12 slices for each group.reperfusion (Po0.05) and there was a tendency for dopamine
content to increase after reperfusion in the 10 min PIC group
(P¼0.057). These data suggest that even after 30 min of OGD the
slice can recover its dopamine synthesising capacity.3.3. Effect of post-PIC incubation on TTC staining in the caudate
In order to examine whether the ﬁrst OGD event was neuro-
toxic we undertook TTC staining to assess mitochondrial activity.
Slices were exposed to OGD for 0, 10, 15 or 20 min then
reperfused for 60 min. There was a signiﬁcant difference in lossg time (min)
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r which the caudate was harvested. When the caudate was examined with 0 min
pamine content (nnPo0.05 vs 0 min PIC), however, in the 60 min incubation slices
In control experiments with 0 min OGD dopamine content fell by about 30% after a
r 30 min OGD with that after a further 60 min incubation it was found that the
in incubation after 30 min PIC). N¼4–8. (B) TTC data: In similar experiments we
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used in either vehicle, MK-801 or DPCPX for 45 min then exposed to a conditioning
resent. The slices were then superfused with normal aCSF for a further 60 min and
e given above (see Table 2 for other parameters). (A) 10 min PIC with OGD-evoked
-on (nPo0.05). In the presence of MK-801 the tolerance evoked by 10 min PIC was
D event 60 min later (nnPo0.05). DPCPX had no effect on OGD but attenuated the
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that there was a loss of TTC staining after 20 min OGD vs both
0 and 10 min OGD (Po0.05, Fig. 4B). Taken together with the FCV
and HPLC data, 10 min PIC evoked tolerance allowed recovery of
dopamine content and did not cause a loss of TTC staining, thus
we used this conditioning time in subsequent experiments.3.4. Does MK-801 block conditioning?
We superfused the caudate slice with MK-801 for 45 min prior
to 10 min OGD conditioning (with MK-801 present during PIC).
We then subjected the slice to a second OGD event 60 min later
and measured the dopamine efﬂux parameters on the second
OGD-evoked dopamine release event. PIC increased T-on after
OGD (F(1, 38)¼37.43, Po0.05). There was no main effect of
MK-801 (F(1, 38)¼0.01, P¼0.93) but there was a PIC  MK-801
interaction (F(1, 38)¼16.12, Po0.05). Post hoc analysis revealed
that PIC increased T-on in the absence of MK-801 (Po0.05), but
there was no PIC-induced increase in T-on in the presence of
MK-801 (P¼0.18). MK-801 also increased T-on in the absence of
PIC (Po0.05). Thus, MK-801 increases T-on in caudate slices that
have not been conditioned, but attenuates the increase in T-on
after PIC (Fig. 5A, Table 2).
MK-801 had no effect on T-peak (F(1, 38)¼2.48, P¼0.13), nor
did PIC (F(1, 38)¼0.5, P¼0.49) and there was no PIC  MK-801
interaction (F(1, 38)¼0.93, P¼0.34). PIC did reduce peak-
dopamine (F(1, 38)¼30.6, Po0.05) but MK-801 had no effect
on peak-dopamine (F(1, 36)¼0.069, P¼0.89) and there was no
PIC  MK-801 interaction (F(1, 36)¼0.14, P¼0.71). PIC decreased
dDA/dt (F(1, 38)¼31.8, Po0.05) as did MK-801 (F(1, 38)¼16.5,
Po0.05) and there was a PIC X MK-801 interaction (F(1, 38)¼9.7,
Po0.05). Thus MK-801 slowed down the rate of dopamine efﬂux
in slices which had not been exposed to PIC, but had no effect in
slices after PIC (Table 2). Taken together, in the absence of PIC,
MK-801 slows down the onset of OGD-evoked dopamine efﬂux
and slows down the rate of dopamine efﬂux.Table 2
Effect of MK-801 and DPCPX on OGD-evoked dopamine efﬂux and conditioning
effects. The dopamine efﬂux parameters of the second OGD-evoked dopamine
efﬂux event are given above (see Fig 5 for T-on).
Efﬂux parameters No conditioning 10 min PIC
No drug MK-801 (10 mM) No drug MK-801 (10 mM)
MK-801 analysis
T-peak (s) 176717 128723 171717 159718
Peak-DA (mM)n 15.571.5 18.071.9 5.771.6 9.471.7
dDA/dt (nM/s)nnn 90717 241726a 37719b 57721c
DPCPX analysis
No drug DPCPX (5 mM) No drug DPCPX (5 mM)
T-peak (s) 176720 146726 171720 195723
Peak-DA (mM)n 15.571.5 11.471.8 5.771.6 7.671.8
dDA/dt (nM/s)n 90717 95720 37719 47718
nPo0.05 main effect of PIC; nnnPo0.05 main effect of PIC and MK-801 and a PIC X
MK-801 interaction, T-peak¼time from the start of dopamine efﬂux to peak
efﬂux; peak-DA¼peak dopamine efﬂux; dDA/dt¼rate of change of dopamine
efﬂux. OGD¼oxygen and glucose deprivation; PIC¼pre-ischaemic conditioning.
N¼6–12 (see Fig 5).
a Po0.05 no drug vs MK-801 with no conditioning i.e. MK-801 slows down
the rate of OGD-evoked dopamine efﬂux.
b Po0.05 PIC vs no PIC (in the absence of MK-801) i.e. PIC reduces the rate of
dopamine efﬂux.
c Po0.05 PIC vs no PIC (in the presence of MK-801) i.e. PIC still slowed down
the rate of dopamine efﬂux even with MK-801 present.3.5. Does DPCPX block conditioning?
We superfused the caudate slice with DPCPX for 45 min prior
to 10 min PIC (with DPCPX present during PIC). We then sub-
jected the slice to a second OGD event 60 min later and measured
the dopamine efﬂux parameters on the second OGD-evoked
dopamine release event. ANOVA revealed a PIC X DPCPX interac-
tion (F(1, 34)¼7.69, Po0.05). Thus PIC increased T-on (po0.05)
and DPCPX reduced the PIC-induced increase in T-on (Po0.05). In
the absence of PIC, DPCPX had no effect on T-on (Fig. 5B). Neither
PIC nor DPCPX had any effect on T-peak (both P40.3) and there
was no effect of DPCPX on dDA/dt (P40.7) or on peak-dopamine
(P40.5; Fig. 5B, Table 2).
3.6. Effect of MK-801 and DPCPX on caudate TTC staining.
There was no signiﬁcant effect of PIC on caudate TTC staining
immediately after the ﬁnal OGD event (F(1, 23)¼0.88, P¼0.36),
however, MK-801 reduced the OGD-evoked loss of TTC staining
(F(1, 23)¼89.5, Po0.05). There was no interaction between PIC
and MK-801 (F(1, 23)¼0.01, P¼0.91). Thus MK-801 attenuated
the loss of TTC staining regardless of whether the slice had been
exposed to PIC or not (Fig. 6A). There was no signiﬁcant effect of
DPCPX on the loss of TTC staining in the caudate immediately
after the ﬁnal OGD event (F(1, 21)¼2.55, P¼0.13) and no
interaction between PIC and DPCPX (F(1, 21)¼1.18, P¼0.29;
Fig. 6B).4. Discussion
We have found that longer conditioning events evoke greater
tolerance to a second OGD event, but possibly at the cost of some
neurotoxicity as determined by TTC staining. We have also shown
that even a 30 min PIC event is not ‘‘lethal’’ as the slice was still
able to synthesise dopamine for up to 60 min after PIC. Our data
suggest that, under these conditions, 10 or 15 min PIC might
afford the best balance between evoking tolerance and not
causing irrevocable toxicity. We then examined receptor mechan-
isms underlying this conditioning phenomenon. We ﬁrst exam-
ined the NMDA receptor antagonist MK-801 both in the absence
and presence of 10 min PIC. In the absence of PIC, MK-801
increased T-on, but decreased T-on 60 min after 10 min PIC. Our
ﬁndings are in agreement with previous work that has demon-
strated the neuroprotective proﬁle of NMDA receptor antagonists
when examining the effects on OGD-evoked dopamine release,
although previous work has not examined PIC. NMDA receptor
antagonists CGS 19755, MK-801 (Toner and Stamford, 1997b) and
ketamine (Mathews et al., 2001) have been shown to increase
T-on. MK-801 also increased T-peak, as did ketamine (Toner and
Stamford, 1997b, Mathews et al., 2001). The NMDA receptor has
an inhibitory Mg2þ binding site and increasing [Mg2þ] from
1.3 to 3.7 mM increased T-peak and decreased dDA/dt (Toner
and Stamford, 1997b). Here, we also show that MK-801 attenu-
ates PIC. These data reveal a complex situation in the rodent
caudate where NMDA receptor activation may have both toxic
and neuroprotective consequences, presumably dependent upon
the degree of NMDA receptor activation. We also found MK-801
to decrease the loss of TTC staining associated with OGD,
consistent with MK-801 having a neuroprotective proﬁle. Adeno-
sine is another transmitter found in high levels in the caudate and
has often been implicated in conditioning effects in the hippo-
campus and cortex (Williams-Karnesky and Stenzel-Poore, 2009).
We examined the adenosine A1 receptor antagonist DPCPX, which
had no effect on T-on or TTC staining during OGD-only but
reduced the effect of PIC on T-on. This suggests that, in the
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Fig. 6. Effect of MK-801 and DPCPX on TTC staining in the caudate with and without PIC. Caudate slices were ﬁrst superfused for 45 min with vehicle, MK-801 (10 mM) or
DPCPX (5 mM) then exposed to either 0 or 10 min PIC, 60 min later they were exposed to 20 min OGD and the tissue was stained with TTC. (A) Immediately after the ﬁnal
OGD event there was an approximate 40% loss in TTC staining, MK-801 attenuated this loss. PIC had no effect on the loss of TTC staining. (B) DPCPX had no effect on TTC
staining. N¼4–8, PIC¼pre-ischaemic conditioning.
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appears to be only involved in PIC and not neuroprotection per se.
A possible explanation for our ﬁnding that PIC delays T-on
could be through OGD-evoked adenosine A1 receptor activation.
Activation of this receptor is proposed to lead to activation of
protein kinase C, and opening of mitochondrial KATP channels.
Hyperpolarisation of the neuron and down-regulation of the
neuronal metabolic and energy dependent mechanisms have
been thought to ensue from opening the neuronal KATP channels
(Nakagawa et al., 2002). Furthermore, opening of the mitochon-
drial KATP channels may depolarise the mitochondrial membrane,
leading to an increase in the electron transport chain activity, and
consequently an increase in ATP production (Inoue et al., 1991;
Perez-Pinzon, 2007). NMDA receptor activation may activate
similar downstream processes (Dirnagl et al., 2003). As a result
of the increased energy availability during a secondary ischeamic
event, either through an increase in ATP synthesis or a decrease in
ATP usage, energy depletion may be delayed. A delay in the
reduction in ATP during OGD would postpone the subsequent
steps in the ischeamic cascade, including anoxic depolarisation
and as a result, caudate dopamine efﬂux.
In addition to increased T-on, other parameters can be asso-
ciated with putative neuroprotection including T-peak, peak-
dopamine and dDA/dt (Toner and Stamford, 1996). Five-minutes
PIC not only delayed T-on but also delayed the T-peak. A delay in
T-peak could be considered neuroprotective by providing more
time for neuronal uptake of released dopamine or diffusion of
dopamine away from the ischeamic site, decreasing peak dopa-
mine concentrations. This could potentially prevent dopamine
reaching neurotoxic levels (Lieb et al., 1995). However, dopamine
reuptake mechanisms have been shown to be compromised
during ischaemia (Kondoh et al., 1995) and it is questionable
how much is taken back up through the transporter during or
after OGD. All PIC events (5–40 min) reduced peak-dopamine on a
subsequent OGD event 60 min later and an obvious explanation
would be reduced dopamine content in the slice after the initial
PIC-evoked dopamine efﬂux. However, HPLC analysis of dopa-
mine tissue content after 60 min post-OGD incubation showed
that 10 min of ischaemia did not signiﬁcantly reduce dopamine
content. Further, dopamine content increased during the 60 min
reperfusion after a 30 min OGD event. Thus the decrease in peak
dopamine found during OGD 60 min after PIC would appear to be
due to tolerance rather than a reduction in caudate dopamine
tissue content. This could be explained by the release of adeno-
sine during ischaemia which has been shown to hyperpolarisepresynaptic membranes, inhibiting further neurotransmitter
release (de Mendonc-a et al., 2000). Furthermore, PIC lowers
calcium inﬂux during a subsequent ischaemia leading to a
putative reduction in neurotransmitter release (Shimazaki et al.,
1998).
We have found MK-801 to attenuate PIC in the caudate.
Blockade of PIC by NMDA receptor antagonists has been achieved
in vivo in the hippocampus (Chen et al., 2008; Bond et al., 1999)
and in vitro (Grabb and Choi, 1999). Furthermore, preconditioning
with NMDA improved synaptic recovery in vitro (Youssef et al.,
2006) and provided reductions in infarct area after microinjec-
tions in the prefrontal cortex in vivo (Saleh et al., 2009). The
present study showed that PIC-evoked neuroprotection was
attenuated in the presence of MK-801, suggesting that NMDA
receptor activation may play a role in rapid (within minutes to
hours) PIC, in the caudate. We also found that the application of
DPCPX prior to and during PIC attenuated the protective effect of
PIC. The blockade of adenosine A1 receptor with DPCPX has been
shown to attenuate PIC in a delayed (Reshef et al., 2000) and rapid
(Nakamura et al., 2002) latency period. Furthermore, mechanisms
thought to be downstream of adenosine A1 receptor activation;
PKC and KATP channel activation, have been elucidated in a variety
of models (Raval et al., 2007). Since increased synthesis and
reduced utilisation of ATP could result from adenosine A1 receptor
activation, the attenuation of this would result in reduced T-on,
which was seen after PIC in the presence of DPCPX. However, as
the delay in T-on was not fully abolished this suggests either (1)
adenosine A1 receptors were not sufﬁciently blocked or (2) the
delay in T-on found is mediated through additional mechanisms
e.g. the NMDA receptor. Even though the delay in T-on was not
fully attenuated the results suggest that during PIC, activation of
adenosine A1 receptors is involved in the cellular pathway
responsible for the tolerance to an OGD insult in the caudate.
There is an apparent mismatch between our voltammetry and
TTC data in that PIC evokes tolerance to a second OGD event but no
apparent tolerance to toxicity, as determined by TTC staining
(Fig. 6). Thus although PIC caused a delay in T-on for the second
OGD event, it had no effect on TTC staining immediately after the
second OGD event. Clearly the caudate tissue is showing tolerance
and this questions what the TTC stain is telling us. TTC turns red
when the mitochondrial dehydrogenase enzymes react with tetra-
zolium salts to form a formazan pigment. Thus, the lack of TTC
staining could simply reﬂect tissue that is compromised rather than
tissue that is dead or dying. The fact that we found a 45% loss of TTC
staining immediately after the OGD event (Fig. 6) but only a 15% loss
N.K. Chauhan et al. / European Journal of Pharmacology 698 (2013) 322–329 329of TTC staining after 60 min reperfusion (Fig. 4) suggests that the
tissue shows some recovery after this OGD event. Others have found
similar recovery in TTC staining on reperfusion (Mathews et al.,
2000). Thus, although PIC does not evoked tolerance to the loss of
TTC staining, we still believe that tolerance to OGD has occurred, as
shown by the increase in T-on.5. Conclusions
Attenuating or slowing ischaemia-evoked dopamine efﬂux
may limit neuronal damage after stroke. We have shown that
brief exposure to OGD in vitro elicits rapid adaptive mechanisms
that delay the onset of dopamine efﬂux during a secondary OGD
episode. We propose that increases in T-on and T-peak are
indicative of neuroprotection as the brain is more tolerant to
subsequent OGD. Our main ﬁnding was that the tolerance
achieved with 10 min conditioning was attenuated in the caudate
by the application of either the adenosine A1 receptor antagonist,
DPCPX or the glutamate-NMDA receptor antagonist, MK-801.
Given that adenosine A1 and NMDA receptors are likely to be
involved in PIC; these could be future targets to induce neuro-
protection pharmacologically. These data, involving OGD-evoked
dopamine efﬂux in the caudate, add to the wealth of data on PIC
from the hippocampus and cortex and suggest receptor mechan-
isms that may be involved in PIC throughout the brain.Acknowledgements
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